Comments
Loading...
Statera BioPharma Stock Guidance | OTC:STAB | Benzinga
Statera BioPharma issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/22/2022 | STAB | Statera BioPharma | FY | 2021 | — | — | — | $1.49M | $1.49M | — | Get Alert |
FAQ
What is the most recent guidance for Statera BioPharma (STAB)?
There have been no specific sales or earnings guidance reported for Statera BioPharma in recent months.
Browse guidance and forecast on all stocks.